Bringing innovative therapies to patients requires more than demonstrating clinical efficacy. It demands the right evidence, value story, pricing strategy and access approach to meet increasingly complex HTA and payer expectations across markets.

IQVIA Health Economics and Market Access helps life sciences companies navigate these decisions from early development through launch and lifecycle management. We connect health economics, HTA, value and access expertise with global data, advanced analytics and AI-enabled capabilities to help clients anticipate evidence requirements, strengthen HTA readiness, inform pricing and access strategy, and demonstrate value to payers.

With 30+ years of global experience, 300+ HEOR experts and access expertise across 35+ countries, IQVIA brings global scale together with regional and local expertise to help accelerate patient access while maximizing long-term product value.

Download the infographic to explore IQVIA Health Economics and Market Access capabilities and expertise.